Enhancements to FDA Draft AI Guidance
ACR® provided comments to the U.S. FDA regarding the draft guidance to address risk management approaches throughout the lifecycle of AI-enabled medical devices.
Read moreGet issue summaries and bill-tracking information for leading federal legislative issues ACR® is monitoring.
We make sure Congress hears the voice of radiology across a variety of healthcare issues.
The “No Surprises Act,” as passed by Congress, held patients harmless and created an equitable provider-insurer independent dispute resolution process. But the interim final rules ignored the law’s intent that a qualified payment amount be among equally weighted factors considered in these disputes. Efforts are ongoing to fix them.
Fight backThe dramatic proliferation in the volume of diagnostic medical imaging services performed by physicians, including non-radiologists, has inflicted a colossal burden on the U.S. healthcare system, especially Medicare.
Read moreEnhancements to FDA Draft AI Guidance
ACR® provided comments to the U.S. FDA regarding the draft guidance to address risk management approaches throughout the lifecycle of AI-enabled medical devices.
Read moreACR Support in Congressional Testimony
ACR submitted congressional testimony in support of funding the National Institute of Health in federal fiscal year 2026.
Read moreCY2026 Medicare Advantage Final Rule
Read moreJoin radiologists across the country who are ensuring that radiology’s voice is heard at the local and federal levels.